Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Menu

Neurostimulation to Treat Parkinson's Disease

AI Biotech/Diagnostics: Other Innovation Patent Forecast®

August 27, 2020

If you have been following our insights over the past few weeks, you have likely seen quite a few insights involving neurostimulation treatments. This relatively new treatment method has been utilized for everything from dieting to epilepsy control. This past week, the National University of Ireland had a patent publish (U.S. Pat. No. 10744324) that teaches using neurostimulation to treat Parkinson's disease. 

Parkinson's disease is a brain disorder that leads to shaking, stiffness, and difficulty with walking, balance, and coordination. Although there is presently no cure for Parkinson's, technologies have been developed to help treat symptoms. One such of those treatments is disclosed in the '4324 patent, which teaches using a combination of sensors and neurostimulation electrodes on the legs to help those who have difficulty walking due to Parkinson's. Make sure to subscribe to the Magic Number® AI Biotech/Diagnostic Patent Forecast® to stay up to date with the most recent patent activity involving emerging treatments and new players to the sector!

Human, Seniors, Old Woman, Lame, Seniorin, Walker

Relevant Patent Documents

Patent US10744324  


View Patent Forecast®

Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.

AI Biotech/Diagnostics: Other Innovation   Patent Forecast®

View Patent Forecast® Top Corporations News and Insights Data Visualization

Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.



301